The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Kennedy Jr. earned more than $2.4 million as a consultant referring cases to the law firm Wisner Baum, government records show. Wisner Baum is suing Merck & Co. over allegations that the ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
Two USAMRICD researchers have been awarded the federal government’s highest honor for outstanding early career scientists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback